BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17822054)

  • 1. [The method and influencing factors of alkalescency protein purification from bitter melon (Momordica charantia) seeds by polyacrylicacid precipitation].
    Zhang HH; Wang QM; Hu JS; Tong FD
    Sheng Wu Gong Cheng Xue Bao; 2007 Jul; 23(4):735-40. PubMed ID: 17822054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extraction, fractionation and characterization of bitter melon seed proteins.
    Horax R; Hettiarachchy N; Over K; Chen P; Gbur E
    J Agric Food Chem; 2010 Feb; 58(3):1892-7. PubMed ID: 20052973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial activity and agricultural properties of bitter melon (Momordica charantia L.) grown in northern parts of Turkey: a case study for adaptation.
    Yaldız G; Sekeroglu N; Kulak M; Demirkol G
    Nat Prod Res; 2015; 29(6):543-5. PubMed ID: 25141891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoaffinity purification of α-momorcharin from bitter melon seeds (Momordica charantia).
    Yao X; Li J; Deng N; Wang S; Meng Y; Shen F
    J Sep Sci; 2011 Nov; 34(21):3092-8. PubMed ID: 21994203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and functionality enhancement by glycosylation of bitter melon (Momordica charantia) seed protein.
    Horax R; Hettiarachchy N; Chen P
    J Food Sci; 2014 Nov; 79(11):C2215-21. PubMed ID: 25350230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioxidant properties and quantitative UPLC-MS analysis of phenolic compounds from extracts of fenugreek (Trigonella foenum-graecum) seeds and bitter melon (Momordica charantia) fruit.
    Kenny O; Smyth TJ; Hewage CM; Brunton NP
    Food Chem; 2013 Dec; 141(4):4295-302. PubMed ID: 23993618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extraction, quantification, and antioxidant activities of phenolics from pericarp and seeds of bitter melons (Momordica charantia) harvested at three maturity stages (immature, mature, and ripe).
    Horax R; Hettiarachchy N; Chen P
    J Agric Food Chem; 2010 Apr; 58(7):4428-33. PubMed ID: 20225855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats.
    Shih CC; Lin CH; Lin WL; Wu JB
    J Ethnopharmacol; 2009 May; 123(1):82-90. PubMed ID: 19429344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on the immunotoxicity of ribosome inhibiting protein of Momordica charantia].
    Wan L; Meng YF; Shen FB; Zheng JC; Deng NH; Zhang LS
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Nov; 40(6):1033-7. PubMed ID: 20067114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a soluble phosphatidic acid phosphatase in bitter melon (Momordica charantia).
    Cao H; Sethumadhavan K; Grimm CC; Ullah AH
    PLoS One; 2014; 9(9):e106403. PubMed ID: 25203006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterisation of an antifungal protein, MCha-Pr, from the intercellular fluid of bitter gourd (Momordica charantia) leaves.
    Zhang B; Xie C; Wei Y; Li J; Yang X
    Protein Expr Purif; 2015 Mar; 107():43-9. PubMed ID: 25245535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy.
    Raina K; Kumar D; Agarwal R
    Semin Cancer Biol; 2016 Oct; 40-41():116-129. PubMed ID: 27452666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review.
    Leung L; Birtwhistle R; Kotecha J; Hannah S; Cuthbertson S
    Br J Nutr; 2009 Dec; 102(12):1703-8. PubMed ID: 19825210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Isolation of plant insulin from Momordica charantia seeds by gel filtration and RP-HPLC].
    Sheng Q; Yao H; Xu H; Ling X; He T
    Zhong Yao Cai; 2004 Jun; 27(6):414-6. PubMed ID: 15524293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of charantin, a napin-like ribosome-inactivating peptide from bitter gourd (Momordica charantia) seeds.
    Parkash A; Ng TB; Tso WW
    J Pept Res; 2002 May; 59(5):197-202. PubMed ID: 11966976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation of Charantin and Expression of Triterpenoid Biosynthesis Genes in Bitter Melon (Momordica charantia).
    Cuong DM; Jeon J; Morgan AMA; Kim C; Kim JK; Lee SY; Park SU
    J Agric Food Chem; 2017 Aug; 65(33):7240-7249. PubMed ID: 28737900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribosome inactivating protein and lectin from bitter melon (Momordica charantia) seeds: sequence comparison with related proteins.
    Wang H; Ng TB
    Biochem Biophys Res Commun; 1998 Dec; 253(1):143-6. PubMed ID: 9875234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMR-based metabolomic profiling of the differential concentration of phytomedicinal compounds in pericarp, skin and seeds of
    Mishra S; Ankit ; Sharma R; Gogna N; Dorai K
    Nat Prod Res; 2022 Jan; 36(1):390-395. PubMed ID: 33438465
    [No Abstract]   [Full Text] [Related]  

  • 19. Lysozyme purification from tobacco extract by polyelectrolyte precipitation.
    Zhang C; Lillie R; Cotter J; Vaughan D
    J Chromatogr A; 2005 Mar; 1069(1):107-12. PubMed ID: 15844488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxicity analysis of active components in bitter melon (Momordica charantia) seed extracts using human embryonic kidney and colon tumor cells.
    Chipps ES; Jayini R; Ando S; Protzman AD; Muhi MZ; Mottaleb MA; Malkawi A; Islam MR
    Nat Prod Commun; 2012 Sep; 7(9):1203-8. PubMed ID: 23074909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.